Revvity (RVTY) Competitors $101.31 +0.41 (+0.41%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$101.22 -0.09 (-0.09%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVTY vs. BRKR, TECH, A, DHR, IQV, MTD, TMO, WAT, KEYS, and VLTOShould you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), Keysight Technologies (KEYS), and Veralto (VLTO). Revvity vs. Its Competitors Bruker Bio-Techne Agilent Technologies Danaher IQVIA Mettler-Toledo International Thermo Fisher Scientific Waters Keysight Technologies Veralto Revvity (NYSE:RVTY) and Bruker (NASDAQ:BRKR) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment. Do analysts rate RVTY or BRKR? Revvity presently has a consensus price target of $123.64, indicating a potential upside of 22.04%. Bruker has a consensus price target of $52.89, indicating a potential upside of 24.68%. Given Bruker's higher possible upside, analysts plainly believe Bruker is more favorable than Revvity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revvity 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.80Bruker 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40 Does the media refer more to RVTY or BRKR? In the previous week, Bruker had 4 more articles in the media than Revvity. MarketBeat recorded 10 mentions for Bruker and 6 mentions for Revvity. Bruker's average media sentiment score of 1.25 beat Revvity's score of 1.23 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revvity 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 9 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is RVTY or BRKR a better dividend stock? Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Revvity pays out 11.9% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Do insiders and institutionals have more ownership in RVTY or BRKR? 86.7% of Revvity shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.7% of Revvity shares are owned by company insiders. Comparatively, 27.3% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is RVTY or BRKR more profitable? Revvity has a net margin of 10.35% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 19.47% beat Revvity's return on equity.Company Net Margins Return on Equity Return on Assets Revvity10.35% 7.73% 4.72% Bruker 2.31%19.47%5.95% Which has more volatility and risk, RVTY or BRKR? Revvity has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Bruker has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Which has stronger valuation & earnings, RVTY or BRKR? Revvity has higher earnings, but lower revenue than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevvity$2.76B4.33$270.39M$2.3543.11Bruker$3.45B1.87$113.10M$0.5281.58 SummaryBruker beats Revvity on 10 of the 19 factors compared between the two stocks. Get Revvity News Delivered to You Automatically Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVTY vs. The Competition Export to ExcelMetricRevvityMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$11.94B$7.31B$5.56B$20.71BDividend Yield0.28%2.78%5.22%3.71%P/E Ratio43.1127.9427.6628.10Price / Sales4.3332.31423.0038.31Price / Cash11.9022.0136.8922.53Price / Book1.616.698.034.58Net Income$270.39M$233.06M$3.18B$985.54M7 Day Performance3.61%3.33%2.93%2.79%1 Month Performance10.13%1.79%1.72%4.37%1 Year Performance-2.17%37.40%34.39%15.08% Revvity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVTYRevvity3.4989 of 5 stars$101.31+0.4%$123.64+22.0%-2.2%$11.94B$2.76B43.1111,000News CoveragePositive NewsBRKRBruker4.7681 of 5 stars$41.20-1.4%$52.89+28.4%-31.2%$6.24B$3.45B79.2311,396Positive NewsTECHBio-Techne4.977 of 5 stars$51.45-0.8%$72.00+39.9%-25.6%$8.07B$1.16B62.743,100Positive NewsAAgilent Technologies4.7382 of 5 stars$118.06-0.9%$140.92+19.4%-4.1%$33.54B$6.51B29.1518,100News CoveragePositive NewsEx-DividendInsider TradeDHRDanaher4.8618 of 5 stars$197.40-0.7%$248.61+25.9%-15.1%$141.27B$23.82B38.3363,000News CoveragePositive NewsIQVIQVIA4.9163 of 5 stars$157.69+0.1%$226.32+43.5%-21.1%$27.28B$15.41B21.4886,000MTDMettler-Toledo International4.2851 of 5 stars$1,175.56-0.8%$1,300.36+10.6%-10.2%$24.43B$3.87B29.3218,000News CoveragePositive NewsTMOThermo Fisher Scientific4.9931 of 5 stars$405.83-0.6%$604.05+48.8%-20.7%$153.20B$42.88B23.80125,000News CoveragePositive NewsWATWaters4.5569 of 5 stars$349.93-0.7%$388.00+10.9%+22.4%$20.82B$2.96B31.758,200Trending NewsAnalyst UpgradeKEYSKeysight Technologies4.3827 of 5 stars$164.05-0.2%$183.00+11.6%+15.3%$28.23B$5.11B38.5115,000News CoveragePositive NewsInsider TradeVLTOVeralto2.9922 of 5 stars$101.030.0%$110.09+9.0%+8.5%$25.04B$5.28B28.8717,000News CoveragePositive News Related Companies and Tools Related Companies Bruker Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Danaher Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Keysight Technologies Alternatives Veralto Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RVTY) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revvity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revvity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.